Astragaloside IV and Ferroptosis Modulation in Pathological Cardiac Hypertrophy: Current Evidence, an Integrative Hypothesis, and Future Directions

Pengbo Liu, Yongzhi Deng · 2026

Read Astragaloside IV and Ferroptosis Modulation in Pathological Cardiac Hypertrophy: Current Evidence, an Integrative Hypothesis, and Future Directions by Pengbo Liu, Yongzhi Deng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13675521.txt.

Description

Pengbo Liu and Yongzhi Deng offer a 2026 review and hypothesis paper on a plant compound and a form of cell death in heart disease. The disease focus is harmful heart muscle growth, which can lead to scarring, weak pumping, and heart failure. The cell death type, called ferroptosis, is driven by iron and damage to cell fats.

The authors weigh signs that this cell death may play a role in the heart condition, while noting the proof does not yet show cause. They then review what is known about the compound, drawn from Astragalus plants, and its effects on swelling, oxidation, and growth. The paper closes with open questions and next steps for lab work. Readers get a clear map of a young research area and its gaps.

Catalog record

CREATORPengbo Liu, Yongzhi Deng
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE75 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13675521

Browse the full library · About the Tower of Babel